Roka Bioscience, Inc. To Report First Quarter 2015 Financial Results On May 7, 2015

WARREN, N.J., April 30, 2015 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced plans to release its financial results for the first quarter of 2015 on May 7, 2015 after the close of the financial markets.

Roka Bioscience will also host a conference call at 4:30 p.m. Eastern Time on May 7, 2015 to discuss its first quarter financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.

To listen to the conference call live, go to http://rokabio.investorroom.com/ or dial 1-888-347-1331 for domestic callers and 1-412-902-4277 for international callers.  A replay of the conference call will be available after the completion of the call by dialing 1-877-344-7529 (domestic) and 1-412-317-0088 (international). The replay access code is 10064525. An online archive of the conference call will also be available at http://rokabio.investorroom.com/.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. 

Contact:

Investor Contact:
Roka Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-report-first-quarter-2015-financial-results-on-may-7-2015-300075442.html

SOURCE Roka Bioscience, Inc.